Post-Operative Eye Drop Protocols After Cataract Surgery: A Complete Evidence-Based Framework

Ask ten cataract surgeons for their postoperative drop protocol and you will receive ten regimens — most of them reasonable, few of them written down for the patient. Yet the postoperative drop regimen is where surgical excellence is either consolidated or squandered: endophthalmitis prophylaxis, inflammation control, CME prevention and ocular surface recovery all depend on what the patient actually instils at home over the following month. This article assembles the evidence into a practical framework for routine and high-risk phacoemulsification, with the adherence engineering that determines whether a protocol survives contact with a real patient in Satna or Salem.

The Four Pharmacological Jobs

Every postoperative regimen addresses four tasks, whether with four bottles or two:

1. Infection prophylaxis — antibiotic, perioperative and early postoperative.
2. Inflammation control — corticosteroid, tapered.
3. CME prevention — NSAID, risk-stratified.
4. Surface protection — lubricant, scheduled.

Task 1: Infection Prophylaxis

The evidence hierarchy is unambiguous. Povidone-iodine antisepsis remains the foundation (Speaker & Menikoff, Ophthalmology 1991). Above it, the ESCRS Endophthalmitis Study (JCRS 2007) demonstrated a five-fold reduction in endophthalmitis with intracameral cefuroxime at wound closure, formalised in the ESCRS 2013 guidelines (Barry, Cordovés, Gardner), and the Cochrane review (Gower et al., 2017) confirmed intracameral antibiotics as the measure with the strongest evidence. Indian high-volume centres have published large series with intracameral moxifloxacin achieving comparable rates — a pragmatic alternative where cefuroxime compounding or allergy is a concern, provided dilution discipline is absolute.

Topically, moxifloxacin 0.5% QID from 1–3 days preoperatively through 7–14 days postoperatively is the standard cover — Moxilux fits this role with the aqueous penetration profile documented in the fluoroquinolone sampling literature. Stop the antibiotic at course end; do not taper.

Task 2: Inflammation Control — The Steroid Taper

Uncontrolled postoperative inflammation costs vision through synechiae, secondary IOP rise and CME. A standard taper for uncomplicated surgery:

Extend and slow the taper for dense lenses, prolonged surgery, capsule rupture, uveitic and paediatric eyes. Check IOP at every review — steroid responses typically appear at 2–6 weeks. For steroid responders and glaucoma suspects, a loteprednol-based regimen or combination attenuates the IOP penalty. Fixed antibiotic-steroid combinations such as Moxilux-D (moxifloxacin-dexamethasone, preservative-free) compress tasks 1 and 2 into one bottle for the highest-risk first fortnight — the period when adherence failure is most costly.

Task 3: CME Prevention — Risk-Stratified NSAIDs

The ESCRS PREMED study (JCRS 2018) and Cochrane data support topical NSAIDs for CME prophylaxis, with the largest absolute benefit in at-risk eyes. Stratify:

• Routine non-diabetic eyes: steroid alone is defensible; NSAID optional.
• Diabetes, epiretinal membrane, uveitis, vein occlusion, prior CME, capsule rupture, PGA use: add nepafenac 0.1% TID (or bromfenac OD–BD) from day −1 to week 4–6 — Nepalux covers this role. Do not stop the NSAID early in at-risk eyes; the CME window peaks at 4–6 weeks.

Task 4: Surface Protection

Surgery destabilises the tear film for weeks; preserved perioperative drops compound the insult. A scheduled preservative-free lubricant — four times daily for the first month, then PRN — improves comfort, epithelial recovery and optical quality. Instil it last in any sequence, at least five minutes after medicated drops.

The Complete Routine Protocol (Uncomplicated Phaco)

Second-Eye Surgery and Recurring Regimens

Bilateral cataract is the norm in Indian practice, and the second eye is an audit opportunity most surgeons underuse. The first eye's course is data: if it flamed with inflammation at week one, intensify the second eye's steroid from day one; if the patient was a proven steroid responder, the second eye starts on a loteprednol-based regimen with earlier IOP checks; if adherence collapsed (and it did for someone), consolidate the second regimen into fewer bottles before it happens again; if CME developed, the fellow eye is automatically in the at-risk stratum and gets full NSAID prophylaxis from day minus three. Documenting first-eye responses in a structured line of the operative note — inflammation course, IOP behaviour, adherence, any CME — converts the second operation from a repeat into an iteration, and it is among the cheapest quality improvements available to any cataract service.

The Dropless Debate: Honest Assessment

Intracameral and intravitreal depot approaches — compounded triamcinolone-moxifloxacin injections, dexamethasone implants, sustained-release phenylephrine-ketorolac inserts — promise freedom from the drop chart entirely. The published outcomes are broadly comparable to topical regimens in selected hands, but the caveats are substantial: compounded preparations carry quality-control and, in past US alerts, retinal toxicity concerns; depot steroids remove the surgeon's ability to titrate against IOP response; costs and regulatory status in India are unsettled; and rescue topical therapy remains necessary in a meaningful minority. For most Indian surgeons in 2026, topical regimens remain the standard — but the dropless literature is worth following, because its premise is correct: the weakest element of any postoperative protocol is the patient's hand, not the surgeon's drug choice. Until depots are routine, fixed combinations and printed schedules are the practical answer to the same problem.

Writing the Protocol Down: The Unit-Level Document

Individual memory-based regimens drift. A one-page unit protocol — displayed in the operating theatre complex and the discharge desk — should specify: preoperative drop loading and antisepsis steps; intraoperative antibiotic policy; the default discharge regimen by risk stratum; taper and stop dates relative to surgery day; review schedule; escalation triggers for inflammation, IOP and non-healing; and the emergency contact pathway. Benefits are immediate: nursing and counsellor instructions become uniform, locum and junior surgeon variation disappears, audit becomes possible, and every discharge counsellor tells the patient the same thing. The best Indian high-volume programmes are built on exactly this kind of unglamorous standardisation.

The First Postoperative Week: What the Slit Lamp Should Change

A protocol is a starting point, not a straitjacket. Day 1 and week 1 findings should actively modify it:

• More inflammation than expected (fibrin, 3+ cells): intensify the steroid before considering anything exotic; recheck in 48–72 hours.
• Corneal oedema disproportionate to surgery: review phaco energy and endothelial status; add hypertonic saline if epithelial oedema persists; manage expectations on clearing time.
• IOP spike: distinguish retained viscoelastic (day 1, settles) from steroid response (week 2+) from pre-existing disease; treat the mechanism.
• Epithelial defect or staining: cut drop frequency where possible, switch to preservative-free, elevate the lubricant to scheduled QID, and suspect toxicity before infection.
• The quiet eye at week 1: complete the course anyway — prophylaxis is not titrated against reassurance.

Adherence Engineering: Where Protocols Actually Fail

A protocol the patient cannot execute is a literature exercise. The predictable failure points, and their fixes:

• Too many bottles: consolidate with fixed combinations; never discharge an elderly patient with four bottles QID if a combination plus lubricant will do.
• No written schedule: give a printed day-by-day chart with tick boxes, in the patient's language, reviewed with the caregiver — not the patient alone.
• Technique: demonstrate instillation in clinic on day 1; insist on five-minute spacing, suspension-shaking, no tip-to-eye contact, and nasolacrimal occlusion.
• Cost abandonment: discuss the full month's cost upfront; a sustainable generic completed beats a premium brand abandoned at day 9.
• Lost-to-follow-up: day 1, week 1–2, and week 4–6 reviews are the minimum; high-risk eyes add a week 6–8 OCT-guided assessment if symptomatic.

Modifying the Protocol: High-Risk Scenarios

• Posterior capsule rupture: extend antibiotic and steroid; mandatory NSAID; lower threshold for intracameral antibiotic; closer IOP surveillance.
• Uveitic eyes: preoperative steroid priming; postoperative courses measured in months with activity-guided tapering; NSAID standard.
• Diabetics: NSAID standard even without retinopathy; OCT at 4–6 weeks for any visual shortfall; surface disease common — lubricants scheduled, not PRN.
• Glaucoma patients: prefer loteprednol-sparing regimens; IOP checks at every visit; beware steroid response compounding existing disease.
• Paediatric cataract: intensive early steroids (inflammation is fiercer), loteprednol preference (steroid response is commoner), combination drops to spare caregivers, and amblyopia management integrated from week 1.

Recognising Trouble: The Safety Net Every Patient Needs

Discharge counselling must name the three postoperative emergencies explicitly:

• Endophthalmitis: increasing pain, redness and falling vision, typically day 2–7 — same-day review, not tomorrow.
• IOP spike: aching pain, headache, haloes, nausea in the first 48 hours.
• Retinal detachment: new floaters, flashes, curtain — any time in the first year.

Give a 24-hour contact route. The patient who waits until morning with endophthalmitis is a protocol failure, however elegant the drop chart.

Frequently Asked Questions

What eye drops are normally prescribed after cataract surgery?

A four-task regimen: a topical antibiotic (typically moxifloxacin QID for 1–2 weeks), a tapering corticosteroid over 3–4 weeks, an NSAID for CME prophylaxis in at-risk eyes, and a scheduled preservative-free lubricant — plus, in many protocols, an intracameral antibiotic at wound closure.

How long do post-cataract eye drops continue?

Antibiotic: 7–14 days, stopped without taper. Steroid: tapered over 3–4 weeks (longer for complex or uveitic eyes). NSAID in at-risk eyes: 4–6 weeks. Lubricant: a month scheduled, then as needed.

What is the evidence for intracameral antibiotics?

The ESCRS randomised study (JCRS 2007) showed a five-fold endophthalmitis reduction with intracameral cefuroxime; the 2013 ESCRS guidelines recommend intracameral prophylaxis, and the 2017 Cochrane review rated it the strongest-evidence measure. Indian series support intracameral moxifloxacin as an alternative with meticulous dilution.

How should multiple post-op drops be sequenced?

Space all drops by at least five minutes; shake suspensions; instil antibiotic first, steroid and NSAID next, lubricant last; use nasolacrimal occlusion for a minute after medicated drops to reduce systemic absorption and washout.

Which symptoms after surgery need urgent review?

Increasing pain with falling vision and redness (endophthalmitis), severe aching with haloes and nausea in the first 48 hours (IOP spike), and new floaters, flashes or a visual field curtain (retinal detachment) — all mandate same-day examination.

---

This article is for educational purposes for healthcare professionals and does not replace clinical judgement or institutional protocols. Regimens must be individualised to surgical course and patient risk.

Oculentis Medical supports complete postoperative care, from antibiotic prophylaxis to NSAID and lubricant therapy. To standardise your post-op protocol with our range, request a sample or contact our medical team.